Literature DB >> 34862492

Secukinumab might improve enthesitis in SpA.

Sarah Onuora1.   

Abstract

Entities:  

Year:  2022        PMID： 34862492     DOI： 10.1038/s41584-021-00734-8

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial.

Authors:  Frank Behrens; Philipp Sewerin; Eugenio de Miguel; Yusuf Patel; Anastas Batalov; Eva Dokoupilova; Christine Kleinmond; Effie Pournara; Ankita Shekhawat; Claudia Jentzsch; Annette Wiedon; Xenofon Baraliakos
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.